The DOI matches its OpenAlex record; 37 of the 37 references it cites were found in a registry or an index.
Foxo1 mediates insulin action on apoC-III and triglyceride metabolism
Open accessAbstract
The apolipoprotein apoC-III plays an important role in plasma triglyceride metabolism. It is predominantly produced in liver, and its hepatic expression is inhibited by insulin. To elucidate the inhibitory mechanism of insulin in apoC-III expression, we delivered forkhead box O1 (Foxo1) cDNA to hepatocytes by adenovirus-mediated gene transfer. Foxo1 stimulated hepatic apoC-III expression and correlated with the ability of Foxo1 to bind to its consensus site in the apoC-III promoter. Deletion or mutation of the Foxo1 binding site abolished insulin response and Foxo1-mediated stimulation. Likewise, Foxo1 also mediated insulin action on intestinal apoC-III expression in enterocytes. Furthermore, elevated Foxo1 production in liver augmented hepatic apoC-III expression, resulting in increased plasma triglyceride levels and impaired fat tolerance in mice. Transgenic mice expressing a constitutively active Foxo1 allele exhibited hypertriglyceridemia. Moreover, we show that hepatic Foxo1 expression becomes deregulated as a result of insulin deficiency or insulin resistance, culminating in significantly elevated Foxo1 production, along with its skewed nuclear distribution, in livers of diabetic NOD or db/db mice. While loss of insulin response is associated with unrestrained apoC-III production and impaired triglyceride metabolism, these data suggest that Foxo1 provides a molecular link between insulin deficiency or resistance and aberrant apoC-III production in the pathogenesis of diabetic hypertriglyceridemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · doi:10.1016/s0092-8674(04)00452-0 · Cited by 1,356
Biggs, W. H., Meisenhelder, J., Hunter, T., Cavenee, W. K., & Arden, K. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7421 · Cited by 1,116
Phosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B
Rena, G., Guo, S., Cichy, S. C., Unterman, T. G., & Cohen, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17179 · Cited by 714
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112876 · Cited by 652
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12876 · Cited by 652
Nakae, J., Biggs, W. H., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616
Kitamura, T., Nakae, J., Kitamura, Y., Kido, Y., Biggs, W., Wright, C. V. E., White, M. F., Arden, K. C., & Accili, D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16857 · Cited by 580
Hypertriglyceridemia as a Result of Human apo CII Gene Expression in Transgenic Mice
Ito, Y., Azrolan, N., O'Connell, A., Walsh, A., & Breslow, J. L. (1990) · Science · doi:10.1126/science.2167514 · Cited by 539
Nakae, J., Park, B.-C., & Accili, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.15982 · Cited by 470
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
Wang, C. S., McConathy, W. J., Kloer, H. U., & Alaupovic, P. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111711 · Cited by 414
O'Brien, R. M., Lucas, P. C., Forest, C. D., Magnuson, M. A., & Granner, D. K. (1990) · Science · doi:10.1126/science.2166335 · Cited by 357
Schmoll, D., Walker, K. S., Alessi, D. R., Grempler, R., Burchell, A., Guo, S., Walther, R., & Unterman, T. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003616200 · Cited by 349
Huard, J., Lochmüller, H., Acsádi, G., Jani, A., Massie, B., & Karpati, G. (1995) · PubMed · Cited by 331
Windler, E., & Havel, R. J. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34342-x · Cited by 314
Maeda, N., Li, H., Lee, D., Oliver, P., Quarfordt, S. H., & Osada, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31559-4 · Cited by 313
Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism
Shachter, N. S. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00009 · Cited by 288
Forkhead transcription factors: new insights into protein kinase B (c-akt) signaling
Kops, G. J. P. L., & Burgering, B. M. T. (1999) · Journal of Molecular Medicine · doi:10.1007/s001099900050 · Cited by 283
Li, W. W., Dammerman, M. M., Smith, J. D., Metzger, S., Breslow, J. L., & Leff, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118324 · Cited by 278
Nakae, J., Barr, V., & Accili, D. (2000) · The EMBO Journal · doi:10.1093/emboj/19.5.989 · Cited by 267
Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion
Rena, G. (2002) · The EMBO Journal · doi:10.1093/emboj/21.9.2263 · Cited by 239
Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice
Altomonte, J., Richter, A., Harbaran, S., Suriawinata, J., Nakae, J., Thung, S. N., Meseck, M., Accili, D., & Dong, H. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00156.2003 · Cited by 227
Self-citationLinkage, evolution, and expression of the rat apolipoprotein A-I, C-III, and A-IV genes.
Haddad, I. A., Ordovas, J. M., Fitzpatrick, T., & Karathanasis, S. K. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69300-7 · Cited by 190
Chen, M., Breslow, J. L., Li, W., & Leff, T. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39938-7 · Cited by 184
Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III.
McConathy, W., Gesquiere, J., Bass, H., Tartar, A., Fruchart, J. C., & Wang, C. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41415-4 · Cited by 173
Kinnunen, P. K. J., & Ehnholm, C. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80145-7 · Cited by 166
FKHR Binds the Insulin Response Element in the Insulin-Like Growth Factor Binding Protein-1 Promoter
Durham, S. K., Suwanichkul, A., Scheimann, A. O., Yee, D., Jackson, J. G., Barr, F. G., & Powell, D. R. (1999) · Endocrinology · doi:10.1210/endo.140.7.6856 · Cited by 146
Jong, M. C., Rensen, P. C. N., Dahlmans, V. E. H., van der Boom, H., van Berkel, T. J. C., & Havekes, L. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32211-2 · Cited by 136
Quarfordt, S. H., Michalopoulos, G. K., & Schirmer, B. D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33329-5 · Cited by 130
Imae, M., Fu, Z., Yoshida, A., Noguchi, T., & Kato, H. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0300253 · Cited by 119
Human apolipoprotein A-I--C-III gene complex is located on chromosome 11.
Bruns, G. A. P., Karathanasis, S. K., & Breslow, J. L. (1984) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.4.2.97 · Cited by 110
Apo A-IV: an update on regulation and physiologic functions
Stan, S., DELVIN, E. E., Lambert, M. A., Seidman, E. G., & Levy, E. H. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(03)00004-0 · Cited by 105
Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in Type II diabetes
Gervaise, N., Garrigue, M. A., Lasfargues, G., & Lecomte, P. (2000) · Diabetologia · doi:10.1007/s001250051366 · Cited by 82
Mann, C. J., Troussard, A. A., Yen, F. T., Hannouche, N., Najïb, J., Fruchart, J., Lotteau, V., André, P., & Bihain, B. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31348 · Cited by 81
Nakae, J., Kitamura, T., Ogawa, W., Kasuga, M., & Accili, D. (2001) · Biochemistry · doi:10.1021/bi015532m · Cited by 78
Groenendijk, M., Cantor, R. M., Blom, N. H. H. C., Rotter, J. I., de Bruin, T. W., & Dallinga‐Thie, G. M. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33507-0 · Cited by 47
Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin
Dallinga‐Thie, G. M., Groenendijk, M., Blom, R. N. H. H. C., de Bruin, T. W., & de Kant, E. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30278-9 · Cited by 27
Hirano, T., Takahashi, T., Saito, S., Tajima, H., Ebara, T., & Adachi, M. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.4.e665 · Cited by 19
Cited by
Pawlak, M., Lefebvre, P., & Staels, B. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.039 · Cited by 1,578
Valsesia, A., Wang, Q.-P., Gheldof, N., Carayol, J., Ruffieux, H., Clark, T., Shenton, V., Oyston, L. J., Lefebvre, G., Metairon, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08492-8 · Cited by 1,073
Redox regulation of FoxO transcription factors
Klotz, L.-O., Sánchez-Ramos, C., Prieto-Arroyo, I., Urbánek, P., Steinbrenner, H., & Monsalve, M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.019 · Cited by 747
“In other studies with transgenic mice, both overexpression of constitutively active Foxo1a as well as knockdown of Foxo1a and Foxo3a likewise resulted in hypertriglyceridemia [232,235].”
BackgroundPathophysiology of diabetic dyslipidaemia: where are we?
Vergès, B. (2015) · Diabetologia · doi:10.1007/s00125-015-3525-8 · Cited by 708
FoxO proteins in insulin action and metabolism
Barthel, A., Schmoll, D., & Unterman, T. G. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.03.010 · Cited by 604
Metadata
- Authors
- Altomonte, J., Lin, C., Harbaran, S., Richter, A. M., Xu, J., Meseck, M. L., & Dong, H. H.
- Venue
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Published
- 2004-11-15
- Volume
- 114
- Issue
- 10
- Pages
- 1493-1503
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2000962819
- Cited by
- 309
- References
- 37
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.